Jefferies Reinstates Buy on AEVEX, Announces $26 Price Target
Jefferies analyst Sheila Kahyaoglu reinstates AEVEX (NYSE:AVEX) with a Buy and announces $26 price target.
Stocks · News reference
AEVEX (NYSE:AVEX) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Jefferies analyst Sheila Kahyaoglu reinstates AEVEX (NYSE:AVEX) with a Buy and announces $26 price target.
Rendering of a jet‑powered, modular Specter variant, which will combine AEVEX’s mission‑proven unmanned aircraft experience with Divergent’s digitally enabled manufacturing approach to support rapid adaptation and
Kahn Swick & Foti, LLC announces class action securities lawsuits against AEVEX Corp., Avis Budget Group, and Hims & Hers Health. AEVEX investors who purchased stock between April 17-June 4, 2026 can join the lawsuit alleging the company concealed a pre-arranged plan to override a 180-day lock-up agreement, allowing major shareholder Madison to sell shares and underwriters to collect additional fees. The application deadline for AEVEX is October 20, 2026.